Administrative Core

摘要 行政核心（ADM）将在我们的第三阶段COBRE的总体监督能力。是 由指导委员会、外部和内部咨询委员会以及其他利益攸关方组成。的adm 核心将由Vince Calhoun博士指导，Vince Calhoun博士是当前提案的PI。它还将根据 一位备受尊敬的精神病临床研究员Juan Bustillo博士和诺拉Perrone-Bizzozero博士的监督， 神经科学家和教育家Jeff Lieberman博士和Charles Bowden博士将担任 外部顾问。核心主任将协调ADM核心的职责和目标，重点是三个目标： 1)协调三个技术核心所需的所有具体预算、管理和人事方面的工作 和试点项目计划; 2）建立一个强大的社区外展计划，并支持新的研究项目 使用我们的试点项目核心;以及3）与以下各方协商，维护并继续发展重要的核心设施： 内部和外部顾问。第三阶段合同的长期目标是扩大我们设施的能力 并进一步发展多元化的神经影像学研究环境， 在国内和国际上。我们相信，通过COBRE第三阶段的支持， 跨学科和转化研究的合作计划可以被利用到中心一级的赠款（例如P41， P50），将在第三阶段奖励开始后约3年提交。因此，第三阶段 该奖项对于我们的新墨西哥州神经精神病多模态成像项目的全面成功至关重要 病

Abstract The administrative core (ADM) will function in an overall supervisory capacity for our Phase III COBRE. It is comprised of a steering committee, external and internal advisory committees, and other stakeholders. The ADM core will be directed by Dr. Vince Calhoun, the PI for the current proposal. It will also operate under the supervision of a well-respected psychiatric clinician-researcher, Dr. Juan Bustillo, and Dr. Nora Perrone-Bizzozero, an established neuroscientist and educator. Drs. Jeff Lieberman, MD and Charles Bowden, MD will serve as external consultants. The core director will coordinate the duties and goals of the ADM core, focused on three aims: 1) to coordinate all the specific budgetary, regulatory, and personnel aspects required in the three technical cores and Pilot Project Program; 2) set up a strong community outreach program and support new investigator projects using our pilot project core; and 3) maintain and continue to develop vital core facilities in consultation with internal and external advisors. A long-term aim of this Phase III award is to expand the capability of our facilities and further develop a diversified neuroimaging research environment that will continue to be competitive nationally and internationally. We believe that through the support of a COBRE Phase III, our cohesive and collaborative program of interdisciplinary and translational research can be leveraged into a center-level grant (e.g. P41, P50) which will be submitted approximately 3 years after the start of the Phase III award. Hence, this Phase III award is essential for the overall success of our New Mexico program on multimodal imaging of neuropsychiatric illness.